Correlation Between Unity Biotechnology and Replimune
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Replimune Group, you can compare the effects of market volatilities on Unity Biotechnology and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Replimune.
Diversification Opportunities for Unity Biotechnology and Replimune
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Unity and Replimune is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Replimune go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Replimune
Considering the 90-day investment horizon Unity Biotechnology is expected to under-perform the Replimune. In addition to that, Unity Biotechnology is 1.08 times more volatile than Replimune Group. It trades about -0.04 of its total potential returns per unit of risk. Replimune Group is currently generating about -0.01 per unit of volatility. If you would invest 2,816 in Replimune Group on September 26, 2024 and sell it today you would lose (1,566) from holding Replimune Group or give up 55.61% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Unity Biotechnology vs. Replimune Group
Performance |
Timeline |
Unity Biotechnology |
Replimune Group |
Unity Biotechnology and Replimune Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unity Biotechnology and Replimune
The main advantage of trading using opposite Unity Biotechnology and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma | Unity Biotechnology vs. Acumen Pharmaceuticals |
Replimune vs. Fate Therapeutics | Replimune vs. Caribou Biosciences | Replimune vs. Karyopharm Therapeutics | Replimune vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |